StreetInsider.com News Articles http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 30 Jun 2026 17:25:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 20-F XTL BIOPHARMACEUTICALS For: Dec 31 http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++XTL+BIOPHARMACEUTICALS++++For%3A+Dec+31/26714941.html si-local-file:///var/storage/secattach/20260630/26714941.html http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++XTL+BIOPHARMACEUTICALS++++For%3A+Dec+31/26714941.html Tue, 30 Jun 2026 17:25:00 -0400 O.00653163 XTLB XTLB Form 20-F XTL BIOPHARMACEUTICALS For: Dec 31 http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++XTL+BIOPHARMACEUTICALS++++For%3A+Dec+31/26714941.html si-local-file:///var/storage/secattach/20260630/26714941.html http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++XTL+BIOPHARMACEUTICALS++++For%3A+Dec+31/26714941.html Tue, 30 Jun 2026 17:25:00 -0400 O.00653163 XTLB XTLB Form 20-F XTL BIOPHARMACEUTICALS For: Dec 31 http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++XTL+BIOPHARMACEUTICALS++++For%3A+Dec+31/26714941.html si-local-file:///var/storage/secattach/20260630/26714941.html http://www.streetinsider.com/SEC+Filings/Form++20-F+++++++XTL+BIOPHARMACEUTICALS++++For%3A+Dec+31/26714941.html Tue, 30 Jun 2026 17:25:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+30/26714825.html si-local-file:///var/storage/secattach/20260630/26714825.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+30/26714825.html Tue, 30 Jun 2026 17:16:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+30/26714825.html si-local-file:///var/storage/secattach/20260630/26714825.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+30/26714825.html Tue, 30 Jun 2026 17:16:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+30/26714825.html si-local-file:///var/storage/secattach/20260630/26714825.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+30/26714825.html Tue, 30 Jun 2026 17:16:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 29 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+29/26707085.html si-local-file:///var/storage/secattach/20260629/26707085.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+29/26707085.html Mon, 29 Jun 2026 16:40:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 29 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+29/26707085.html si-local-file:///var/storage/secattach/20260629/26707085.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+29/26707085.html Mon, 29 Jun 2026 16:40:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 29 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+29/26707085.html si-local-file:///var/storage/secattach/20260629/26707085.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+29/26707085.html Mon, 29 Jun 2026 16:40:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+22/26675289.html si-local-file:///var/storage/secattach/20260623/26675289.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+22/26675289.html Tue, 23 Jun 2026 06:02:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+22/26675289.html si-local-file:///var/storage/secattach/20260623/26675289.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+22/26675289.html Tue, 23 Jun 2026 06:02:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: Jun 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+22/26675289.html si-local-file:///var/storage/secattach/20260623/26675289.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+Jun+22/26675289.html Tue, 23 Jun 2026 06:02:00 -0400 O.00653163 XTLB XTLB XTL Biopharmaceuticals receives additional Nasdaq delist notice http://www.streetinsider.com/Corporate+News/XTL+Biopharmaceuticals+receives+additional+Nasdaq+delist+notice/26541730.html <p>XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) received a staff determination letter from Nasdaq on May 18 regarding an additional delisting matter, the company announced.</p><p>The Nasdaq Listing Qualifications Department notified XTL that it no longer complies with Listing Rule 5250(c)(1) because the company has not filed its Annual Report on Form 20-F for the year ended December 31, 2025. The rule requires companies to timely file all required periodic financial reports with the SEC.</p><p>This filing deficiency serves as an additional basis for delisting XTL's securities from Nasdaq. The Nasdaq Hearings Panel will consider this matter alongside the company's existing compliance issues when http://www.streetinsider.com/Corporate+News/XTL+Biopharmaceuticals+receives+additional+Nasdaq+delist+notice/26541730.html Fri, 22 May 2026 16:11:50 -0400 XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+22/26541732.html si-local-file:///var/storage/secattach/20260522/26541732.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+22/26541732.html Fri, 22 May 2026 16:11:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+22/26541732.html si-local-file:///var/storage/secattach/20260522/26541732.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+22/26541732.html Fri, 22 May 2026 16:11:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+22/26541732.html si-local-file:///var/storage/secattach/20260522/26541732.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+22/26541732.html Fri, 22 May 2026 16:11:00 -0400 O.00653163 XTLB XTLB XTL Announces Receipt of Staff Delist Determination from Nasdaq http://www.streetinsider.com/Press+Releases/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html <p align="justify">RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), dated May 18, 2026, notifying the Company that since the Company has not yet filed its Annual Report on Form 20-F for the year ended December 31, 2025, it no longer complies with Nasdaq’s Listing Rule Listing Rule 5250(c)(1) which requires companies to timely file all required periodic financial reports with the SEC.</p> http://www.streetinsider.com/Press+Releases/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html Fri, 22 May 2026 16:10:00 -0400 XTLB XTLB XTL Announces Receipt of Staff Delist Determination from Nasdaq http://www.streetinsider.com/Press+Releases/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html <p align="justify">RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), dated May 18, 2026, notifying the Company that since the Company has not yet filed its Annual Report on Form 20-F for the year ended December 31, 2025, it no longer complies with Nasdaq’s Listing Rule Listing Rule 5250(c)(1) which requires companies to timely file all required periodic financial reports with the SEC.</p> http://www.streetinsider.com/Press+Releases/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html Fri, 22 May 2026 16:10:00 -0400 XTLB XTLB XTL Announces Receipt of Staff Delist Determination from Nasdaq http://www.streetinsider.com/Globe+Newswire/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html <p align="justify">RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), dated May 18, 2026, notifying the Company that since the Company has not yet filed its Annual Report on Form 20-F for the year ended December 31, 2025, it no longer complies with Nasdaq’s Listing Rule Listing Rule 5250(c)(1) which requires companies to timely file all required periodic financial reports with the SEC.</p> http://www.streetinsider.com/Globe+Newswire/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html Fri, 22 May 2026 16:10:00 -0400 XTLB XTLB XTL Announces Receipt of Staff Delist Determination from Nasdaq http://www.streetinsider.com/Globe+Newswire/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html <p align="justify">RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), dated May 18, 2026, notifying the Company that since the Company has not yet filed its Annual Report on Form 20-F for the year ended December 31, 2025, it no longer complies with Nasdaq’s Listing Rule Listing Rule 5250(c)(1) which requires companies to timely file all required periodic financial reports with the SEC.</p> http://www.streetinsider.com/Globe+Newswire/XTL+Announces+Receipt+of+Staff+Delist+Determination+from+Nasdaq/26541663.html Fri, 22 May 2026 16:10:00 -0400 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 15 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+15/26507727.html si-local-file:///var/storage/secattach/20260515/26507727.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+15/26507727.html Fri, 15 May 2026 17:09:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 15 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+15/26507727.html si-local-file:///var/storage/secattach/20260515/26507727.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+15/26507727.html Fri, 15 May 2026 17:09:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 15 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+15/26507727.html si-local-file:///var/storage/secattach/20260515/26507727.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+15/26507727.html Fri, 15 May 2026 17:09:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 07 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+07/26448957.html si-local-file:///var/storage/secattach/20260507/26448957.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+07/26448957.html Thu, 07 May 2026 08:10:00 -0400 O.00653163 XTLB XTLB Form 6-K XTL BIOPHARMACEUTICALS For: May 07 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+07/26448957.html si-local-file:///var/storage/secattach/20260507/26448957.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++XTL+BIOPHARMACEUTICALS++++For%3A+May+07/26448957.html Thu, 07 May 2026 08:10:00 -0400 O.00653163 XTLB XTLB